Groundbreaking Collaboration Between Manifold Bio and Roche Launches $2B-Plus Brain-Shuttle Program
Manifold Bio inks a groundbreaking collaboration with Roche to apply AI-guided brain-shuttle technology for neurological therapies.
Industry Trends
NextGen Gene Editing Breakthroughs Redefine Personalized Care
The New Frontier of Gene Editing: From Precision Tools to Personalized Therapies A new generation of programmable gene editing tools is pushing biotechnology toward an era of truly personalized medicine one in which therapies are tailored not only to specific diseases but to individual genetic profiles. As highlighted in a recent npj Biomedical Innovations feature … Read more
Metsera responds to Pfizer lawsuit, defends board process in Novo bid dispute
Pfizer’s GLP-1 lawsuit tests biosimilar ambitions and contract guardrails.
Brensocatib faces ICER spotlight with strong case for clinical and economic value
ICER pegs an ~$88K benchmark for brensocatib and spotlights evidence gaps shaping NCFB access.
Novo’s unsolicited bid for Metsera challenges Pfizer pact
Novo’s unsolicited Metsera bid could upend Pfizer pact and reshape the GLP-1 race.
Reimbursement Series: CMS and Europe Reimbursement Pathway Accelerates Innovation
In a transformative week for market access, the CMS and Europe reimbursement pathway expansion delivered several pivotal coverage and pricing decisions reshaping patient access across cardiovascular, hepatic, and oncology therapies. From CMS’s national determinations on breakthrough devices to European HTA approvals in rare disease and cancer, these developments underscore a growing transatlantic alignment between regulators … Read more
New Proposal Calls for Funeral Reimbursement to Boost U.S. Organ Donation
Funeral reimbursement could transform U.S. organ donation access and equity.
Evernorth Secures Breakthrough Pricing Shift in Drug Access
Evernorth’s pricing model overhaul transforms drug access and reimbursement dynamics.
Baird Medical Secures Pivotal Reimbursement Win for MWA
Successful reimbursement milestone strengthens device adoption and access strategy.
Sprouts Launches Bold Lawsuit Challenging Insulin Pricing
Sprouts files lawsuit over insulin pricing scheme and PBM collusion.